WebmedCentral Editor
View all WebmedCentral Editors
No Image

Dr. Noton Dutta

Faculty Research Associate
Center for Tuberculosis Research,Johns Hopkins School of Medicine
1503 E Jefferson Street, Room # 122

Brief Biography:

Career History: 2000-2001 - Research Trainee, Dept. of Microbiology and Parasitology, Calcutta University College of Medicine, Kolkata, India. 2001-2004 - Project Scientist, Division of Microbiology, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. 2004-2006 - Lecturer, Department of Microbiology, Institute of Genetic Engineering, University of Kalyani, Kolkata, India. 2006-2008- Postdoctoral Fellow, Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Korea. 2008-2011- Postdoctoral Fellow, Tulane National Primate Research Center, Covington, LA, USA. 2011- present- Postdoctoral Fellow, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Academic positions:

Other Experience and Professional Membership 2008-Member, American Society for Microbiology (ASM) 2004-Member, International Society for Infectious Diseases (ISID) 2004-Life Member, International Society of Non-antibiotics (ISN) 2004-Life Member, Asian Network of Research on Antidiabetic Plants (ANRAP) 2004-Life Member, Indian Association of Medical Microbiologists (IAMM) 2004-Life Member, Association of Microbiologists of India (AMI) 2004-Life Member, Hospital Infection Society of India (HIS). Editorial board Member 2011-2015-World Journal of Clinical Infectious Diseases (http: //www.wjgnet.com) 2011-2015-Clinical Reviews and Opinions (www.academicjournals.org/CRO) Journal peer review activities 2011-present-Indian Journal of Medical Microbiology 2011-present-African Journal of Pharmacy and Pharmacology 2010-PLosONE

Research interests:

I am working on multiple projects focusing on studies characterizing the efficacy of novel drugs and drug combinations against M. tuberculosis (Mtb) in murine and guinea pig models and searching for new anti-TB drug targets, with the goal of shortening the duration of TB chemotherapy. To this end, I am following two different approaches: i) characterization of Mtb transcriptional responses to new anti-TB compounds and use of bioinformatics to identify relevant drug targets; ii) use of multidisciplinary techniques, including computational modeling and high throughput genetic screens in various animal models, in order to elucidate Mtb essential pathways involved in latency and reactivation.

What I think of the idea behind WebmedCentral:

I like this novel idea for an impartial peer reviewed judgment in biomedical journal